Journal of Dental Pathology and Medicine
Open Access

Atrial fibrillation (AF) is a common cardiac arrhythmia characterized by irregular, often rapid heartbeats. It has been a subject of extensive research due to its association with an increased risk of stroke, heart failure, and other cardiovascular complications. While traditional risk factors for AF, such as hypertension, diabetes, and obesity, have been well-established, emerging evidence suggests that oral inflammatory diseases may also play a significant role in its development and progression. This comprehensive review aims to explore the connection between oral inflammatory diseases and AF, shedding light on the potential mechanisms and clinical implications of this association [1].

In addition, C-reactive protein, interleukin-6, tumor necrosis factor-α, and other inflammatory factors can cause an abnormal electrical activity of pulmonary veins, shorten atrial action potential, and interact with heat shock protein or myeloperoxidase to promote atrial fibrosis, thereby promoting the occurrence and recurrence of atrial fibrillation and thromboembolic events [2].

Oral inflammatory diseases are evolving chronic diseases. Periodontitis (PD) is a major oral health problem, leading to tooth loss and bacteremia and resulting in systemic inflammatory responses in severe cases. Surveys show that approximately 50% of the world’s population suffers from PD and 10% suffer from severe PD, which is considered to be the sixth global epidemic affecting every country. Based on common risk factors and underlying pathophysiological mechanisms, increasing attention has been given to the association between oral diseases and cardiovascular diseases [3]. Studies have shown that in PD patients, Porphyromonas gingivalis and inflammatory factors could promote the progression of atherosclerosis and may be potential risk factors for coronary heart disease. PD can increase the risk of hypertension through systemic inflammation and oxidative stress.

The oral-heart connection

The oral cavity is not an isolated entity but rather an integral part of the human body. It is home to a diverse microbiome, and disruptions in its balance can lead to various oral inflammatory conditions. Periodontal disease, gingivitis, and dental infections are examples of these inflammatory disorders [4]. Such conditions can lead to the release of pro-inflammatory cytokines, bacterial toxins, and immune responses that may influence distant organs and systems, including the cardiovascular system [5].

Inflammation and atrial fibrillation

Inflammation has long been recognized as a crucial player in the development and exacerbation of cardiovascular diseases. In the context of AF, it is believed that the systemic inflammation triggered by oral diseases can affect the myocardium and conduction system, leading to electrical and structural remodeling. This, in turn, can promote the initiation and maintenance of AF [6].

Mechanisms of influence

Several potential mechanisms underlie the relationship between oral inflammatory diseases and AF. These mechanisms include:

Inflammatory mediators: The release of inflammatory mediators like interleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-α) from oral inflammation may promote atrial inflammation and fibrosis, contributing to the development of AF [7].

Endothelial dysfunction: Oral inflammatory diseases can impair endothelial function, leading to increased oxidative stress and reduced nitric oxide bioavailability [8]. This endothelial dysfunction may contribute to AF by affecting the endothelium of the atria.

Microbiota dysbiosis: An altered oral microbiota composition may lead to the translocation of oral pathogens into the bloodstream, potentially causing systemic inflammation and impacting cardiac health [9].

Autonomic nervous system activation: Local inflammation in the oral cavity can activate the sympathetic nervous system, which is known to influence atrial electrophysiology and increase the likelihood of AF.

Clinical Implications

Understanding the link between oral inflammatory diseases and AF has clinical implications. Dentists and cardiologists should collaborate more closely to identify patients at risk and develop integrated care plans. For patients with AF, maintaining good oral health may be an adjunctive strategy to reduce the risk of AF recurrence and complications [10].

Conclusion

The connection between oral inflammatory diseases and atrial fibrillation is an emerging field of research that holds promise for improving our understanding of the multifactorial nature of AF. While more research is needed to establish the exact mechanisms and causality, the evidence suggests that maintaining good oral health is not only important for oral well-being but may also have a positive impact on cardiovascular health. Recognizing the intricate relationship between oral and cardiac health is a step toward more holistic approaches to patient care and cardiovascular disease management. Further studies are needed to validate the clinical utility of addressing oral inflammatory diseases as part of AF prevention and treatment strategies.

1. Khader YS, Rice JC, Lefante JJ (2003) Factors Associated with Periodontal Diseases in A Dental Teaching Clinic Population in Northern Jordan. J Periodontol 74: 1610-1617.

Indexed at , Google Scholar , Crossref

2. Chaffee BW, Rodrigues PH, Kramer PF, Vítolo MR, Feldens CA (2017) Oral Health-Related Quality-of-Life Scores Differ by Socioeconomic Status and Caries Experience. Community Dent Oral Epidemiol 45: 216-224.

Indexed at , Google Scholar , Crossref

3. Bergenholtz G, Mjör IA, Cotton WR, Hanks CT, Kim S, et al. (1985) The Biology of Dentin and Pulp: Consensus Report. J Dent Res 64: 631-633.

Indexed at , Google Scholar , Crossref

4. Liu G, Yang Y, Min KS, Lee BN, Hwang YC (2022) Odontogenic Effect of Icariin on the Human Dental Pulp Cells. Medicina (Kaunas) 58: 434.

Indexed at , Google Scholar , Crossref

5. Leslie JE, Marazita LM (2013) Genetics of Cleft Lip and Cleft Palate. Am J Med Genet C Semin Med Genet 163: 246-258.

Indexed at , Google Scholar , Crossref

6. Shkoukani AM, Chen M, Vong A (2013) Cleft Lip – A Comprehensive Review. Front Pediatr 1: 53.

Indexed at , Google Scholar , Crossref

7. Burg LM, Chai Y, Yao AC, Magee W, Figueiredo CJ (2016) Epidemiology, Etiology, and Treatment of Isolated Cleft Palate. Front Physiol 7: 67.

Indexed at , Google Scholar , Crossref

8. Khan ANMI, Prashanth CS, Srinath N (2020) Genetic Etiology of Cleft Lip and Cleft Palate. AIMS Molecular Science 7: 328-348.

Indexed at , Google Scholar , Crossref

9. Schutte BC, Murray JC (1999) The many faces and factors of orofacial clefts. Hum Mol Genet 8: 1853-1859.

Indexed at , Google Scholar , Crossref

10. Bender PL (2000) Genetics of cleft lip and palate. J Pediatr Nurs 15: 242-249.

Indexed at , Google Scholar , Crossref